Current evidence has shown antioxidant activity of artichoke as a potent source of antioxidant compounds. However, it seems that the antioxidant activity of artichoke
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It is hypothesized that the head and leaves of artichoke and their extract could protect the body against oxidative stress induced by various active oxidant or toxins. Although there are some narrative review studies on medicinal effects of artichoke, it seems that the antioxidant effects of artichoke and its extract has not yet been systematically reviewed. Accordingly, the present study was designed to review the antioxidant effects of Cynara scolymus in human studies, animal models and in vitro systems. Furthermore, this study was set out to perform a meta-analysis on the effects of artichoke supplementation on superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione peroxidase (GPx), and malondialdehyde (MDA) level in liver, as well as, MDA level in plasma using data from animal studies.
| MATERIALS AND METHODS

| Article selection
We searched PubMed/Medline, Scopus, the Cochrane Library, and Google scholar electronic databases. The search terms were "C. scolymus" or "artichoke," "Cynara cardunculus"or "cynara," "oxidative stress" or "free radicals," "free radical scavengers" or "glutathione peroxidase," "reactive oxygen species" or "oxidized low density lipoprotein," "antioxidants" or "total antioxidant status," and "total antioxidant capacity" or "superoxide dismutase." Two authors (K.R., S.S.)
independently conducted the searching and data extraction, and then duplicated studies were deleted. Overall, there was an agreement between authors on the selection of studies, and some differences were resolved by third the author (M.E.).
We included only English-language articles published from 1995 until April 2018. We excluded review articles, abstracts in congress, case reports, and articles that examined the effects of artichoke mixed with other plants, or examined other properties of artichoke. We also excluded mechanistic studies on artichoke compounds, irrelevant articles, and studies on Jerusalem artichoke (Helianthus tuberosus L.).
We hand searched the references of included studies. After critical appraisal of articles, 39 articles were selected and reviewed (two 
| Data extraction
We extracted the following information from the full-text papers of eligible studies: the first author, publication year, subject characteristics, sex, age, weight, type of intervention, dosage, duration of study, sample size per comparison group, and results of studies on oxidant/ antioxidant parameters. A summary of the included studies is presented in Tables 1-3. We also extracted the means and SDs of SOD, CAT, GSH, GPx, and MDA level in liver and MDA level in plasma from the animal studies for both intervention group (defined as animals with induced disease supplemented with artichoke) and comparison group (defined as animals with induced disease). For articles with missing SDs for outcome values, SDs were calculated from standard error.
We used final values of outcomes only if quantitative data were provided or could be estimated from graphs. When two or more doses of artichoke were evaluated in the same study, each dose was compared independently with comparison group.
| Quality assessment
The assessment of risk of bias was undertaken using the Cochrane collaboration's tool (Higgins et al., 2011) for randomized clinical trials and SYRCLE's risk of bias tool (Hooijmans et al., 2014) for animal studies.
The SYRCLE's risk of bias tool is an adapted version of the Cochran risk of bias tool for animal intervention studies. Both tools cover six domains of bias: selection bias, performance bias, attrition bias, detection bias, reporting bias, and other sources of bias. Risk of bias is judged as low, unclear, or high in each domain. The risk of bias of in vitro studies were not assessed, as no validated tool was available (Krithikadatta, Gopikrishna, & Datta, 2014) .
The risk of bias in the eligible studies was evaluated independently by three authors and disagreements on scores were resolved through discussion.
| Data analysis
Although we aimed to perform meta-analysis for human, animal, and in vitro studies, a reliable meta-analysis was not possible for human and in vitro studies due to restriction in number and comparable outcomes. For animal studies, effect estimates were calculated using standardized mean differences (SMD; Hedges's g) and a 95% confidence interval (CI) to report the size of artichoke effect on oxidant/ antioxidant indices by accounting the differences in the units of measurements in different studies. Data were pooled using a random effects model to account for anticipated heterogeneity.
Heterogeneity was examined using I-squared statistic ( Meta-regression and subgroup analysis were implemented to identify potential sources of between-study heterogeneity, including study duration, dosage of supplement, and induced disease. Publication bias was assessed by visual evaluation for funnel plot asymmetry and Egger's linear regression test. Sensitivity analyses were also performed to examine the effect of each studies on overall pooled estimates and heterogeneity. The sensitivity analysis was conducted to identify the impact of each study on the pooled effect size. All data analysis was conducted using Stata 12.0 software (StataCorp LP, College Station, TX).
3 | RESULTS
| Study characteristics
The included studies were categorized into human, animal, and in vitro studies. Characteristics of included studies are summarized in Note. FMLP: N-formyl-methionyl-leucyl-phenylalanine; GPx: glutathione peroxidase; GR: glutathione reductase; GSH: glutathione; GST: glutathione-S-transferase; HUVEC: human umbilical endothelial cell; LPS: lipopolysaccharide; MDA: malondialdehyde; NHEK: human epidermal keratinocyte; ox-LDL: oxidized-LDL; PMA: phorboM2-myristate-13-acerate; ROS: reactive oxygen species; UVA: ultraviolet-A; UVB: ultraviolet-B
| Human studies
The antioxidant effects of artichoke were reported just in two human studies (Rezazadeh, Aliashrafi, et al., 2018; Skarpanska-Stejnborn et al., 2008) . Skarpanska-Stejnborn et al. (2008) evaluated the effects of supplementation with artichoke leaf extract (1,200 mg/day) on antioxidant defense system in 22 members of the Polish rowing team for 5 weeks. The subjects performed a 2,000-meter rowing exercise test before and after the study. The redox parameters were measured before each test, 1 min after the test finished, and after a 24-hr restitution period. The supplementation resulted in significant increase of total antioxidant capacity after restitution in intervention group compared with placebo group. However, the activity of SOD, GPx and glutathione reductase (GR) as well as reduced glutathione levels (GSSG) and thiobarbituric-acid-reactive-substances concentrations did not change significantly during experimental period. Our recent doubleblind, randomized controlled trial on 80 patients with metabolic syndrome indicated that supplementation with hydroalchoholic extract of artichoke leaf (1800 mg/day) decreased significantly oxidized-LDL (ox-LDL) level compared with placebo after 12 weeks. But, there were no significant differences in MDA, SOD, GPx, and total antioxidant capacity levels between and within groups (Rezazadeh, Aliashrafi, et al., 2018) .
| Animal studies
The effect of artichoke on the improvement of antioxidant defense system is supported by finding from different animal studies as shown in Table 2 . Based on inclusion criteria, 23 animal studies were included in this systematic review. Kamel, 2015) , and in mice with acute alcohol-induced liver injury (Tang et al., 2017) showed similar results favor to protect liver from toxicity induced by paracetamol and alcohol. But, Mehmetcik et al. (2008) observed that MDA and DC levels decreased and GPx activity and GSH level increased, whereas SOD activity and levels of vitamin E and vitamin C did not change significantly in liver tissue of rats with carbon tetrachloride-induced hepatic injury after administration of artichoke leaf extract (1.5 mg/kg) for 2 weeks.
El-Boshy et al. (2017) assessed the effects of hydroalcoholic extract of artichoke leaf (300 mg/kg) against cadmium (Cd) toxicity in rats. In Cd-and artichoke leaf extract-treated group, liver MDA significantly decreased compared with Cd-treated group, whereas the kidney peroxidation (MDA) and the liver and kidney antioxidant markers, SOD, GPx, CAT, and GSH did not change significantly compared with intoxicated rats.
The beneficial antioxidant effects of artichoke leaf extract have also been indicated in other organ toxicity such as nephrotoxicity (Khattab et al., 2016) and cardiotoxicity (Najim et al., 2015) . Moreover, artichoke leaf extract was effective in attenuation of elevated level of MDA and reduced level of GSH in kidney of rats with ethylene glycolinduced urolithiasis (Jaleel et al., 2016) . Also, supplementation with artichoke leaf extract in rats fed with lead-containing diet decreased their MDA level and increased FRAP level (Heidarian & RafieianKopaei, 2013) . In ageing rats model induced by d-galactose, reduced level of MDA and elevated activity of SOD, GPx and, CAT were shown after artichoke leaf extract consumption (Song et al., 2012) . heads supplementation led to increase of GPx level in liver, heart, and blood and to decrease of MDA level in liver, heart, and blood in hypercholesterolemic rats (Magied, Hussien, Zaki, & Said, 2016) . In addition, another study reported that administration of aqueous extract of artichoke leaf to hypercholesterolemic rats resulted in a significant decrease of ox-LDL and antioxidized-LDL level (Mocelin et al., 2016) . However, Kucukgergin et al. (2010) showed that artichoke leaf extract decreased MDA and DC level in liver and heart and increased GPx, GST, and vitamin E in liver but did not change SOD, GSH, and vitamin C in liver and heart of hypercholesterolemic rats.
Studies on normal rats showed that consumption of the edible portion of artichoke (~14% of diet) resulted in more favorable antioxidant status (Goñi et al., 2005; Jiménez-Escrig et al., 2003) . 
| Risk of bias
The results of assessment of risk of bias for randomized clinical trial and animal studies are presented in Figure 2 . The unclear risk of bias was detected in selection bias (n = 22, because of the lack of knowledge on the method of randomization), performance bias (n = 3, because of absence of knowledge on blinding of participants or caregivers), and detection bias (n = 22, because of absence of infor- The sensitivity analysis indicated that removal of each study did not greatly affect overall meta-analysis estimates. Even after excluding the study of Song et al. (2012) with very low dose of supplement, the overall effect size did not change significantly (SMD: 1.31, 95% CI: 0.59, 2.03).
| Liver CAT
The quantitative analysis of liver CAT (nine datasets) indicated a significant improvement in intervention group compared with comparison group (SMD: 2.51, 95%CI: 1.21, 3.81, I2 = 85.4%; Figure 4 ). This improvement was significant in animals with less than 1,000 mg/kg supplementation of artichoke extract (SMD: 2.36, 95%CI: 0.86, 3.86, p = 0.002). On the contrary, in animals with equal or more than 1,000 mg/kg, no significant effect of artichoke extract supplementation was observed (SMD: 3.23, 95%CI: -0.37, 6.83, p = 0.079). Heterogeneity in subgroups was also high.
Based on the results of meta-regression analysis, dosage, study duration, and induced disease did not affect pooled estimates. The sensitivity analysis showed that the pooled SMD and 95% CIs were not changed by excluding each study. The finding of metaregression analysis showed that duration, dosage, and type of induced disease were not source of heterogeneity of plasma MDA.
| Publication bias
The funnel plot for the effects of artichoke extract on liver SOD, liver GSH, liver GPx, and liver MDA indicated an asymmetry (Figures 9a, 9b, 9c, 9d, 9e). The Egger's regression also confirmed the publication bias (p < 0.05). However, when these publication biases were corrected using trim and fill method by adding theoretically missing studies, the results did not change significantly (data not shown).
On the basis of a funnel plot (Figure 9f ) and Egger's statistical test, there was no publication bias for plasma MDA.
| DISSCUSION
In the present study, we systematically reviewed the antioxidant activ- the present meta-analysis. Based on our finding, artichoke extract in low dosage (<1000 mg/kg) for a short duration (<20 days) are suggested as potent antioxidant in animals, mostly rats with hepatotoxicity. However, due to insufficient number of studies in many of the subgroup analysis and highly heterogeneous data, probably resulting of differences in design and quality, we cannot draw a conclusion for recommending dosage of artichoke extract and duration of study for human studies.
Free radicals and ROS at moderate concentrations play an important role in control of cell function; however, at high concentrations, they can be an important mediator to injure all major cell structures, including proteins, lipids, and DNA. Antioxidant defense system, existing in most living organisms, can scavenge free radicals and be classified into two major groups: enzymatic antioxidants (SOD, CAT, GPx, and GSH) and nonenzymatic antioxidants (vitamin E, vitamin C, carotenoids, flavonoids, polyphenols, and others). The "redox homeostasis" is determined by balance between the production of free radicals and ROS and their elimination by various antioxidants (Fang, Yang, & Wu, 2002) . Antioxidants found in some herbs could help enhance the body's innate defense system and maintain redox balance (Rubió et al., 2013) . (Carlsen et al., 2010) . Furthermore, even artichoke byproducts extract indicated high content of phenolic compounds that could be used as antioxidant in meat products (Ergezer & Serdaroğlu, 2018) .
There are several methods for determination of bioactive compounds of artichoke. Recently, fingerprinting C. scolymus was performed by a high-performance liquid chromatography-photodiode array detection method that is an efficient and green method for the desired separation and save environmental resources (Souza, Carneiro, Vieira, Funari, & Rinaldo, 2018) . The pharmacokinetics assessment of artichoke extract (Wittemer et al., 2005) and cooked edible artichoke (Azzini et al., 2007) in human subjects confirmed the bioavailability of metabolites derived from caffeoylquinic acids and flavoniods not as free but as conjugated to sulfuric or glucuronic acid in plasma and urine after consumption.
It is hypothesized that the antioxidant activity of artichoke might be related to following compounds: (a) polyphenolics (caffeoylquinic acids and flavonoids) and (b) Sesquiterpenes (Ben Brown & Rice-Evans, 1998; Gebhardt, 1997; Miccadei et al., 2008; Miláčková et al., 2017; Perez-Garcia et al., 2000; Rahimuddin et al., 2007; Takei et al., 2015) .
• 1. Polyphenolic compounds:
• ( Perez-Garcia et al., 2000) . Recently, the antioxidant activity of chloregenic acid and cynarin was shown using various in vito antioxidant assays (Sato et al., 2011; Topal et al., 2016) . Within the caffeoylquinic acid derivatives of artichoke, the content of cynarin and chlorogenic acid is about 1.5% and 39%, respectively, which is highly varied in different part of plant (i.e., leaves, outer bracts, inner bracets, and head) and different regions (Lattanzio, Kroon, Linsalata, & Cardinali, 2009 ).
• ( human skin fibroblasts (Rahimuddin et al., 2007) and also against in vitro oxidation of LDL isolated from healthy volunteers (Brown & Rice-Evans, 1998 ).
The antioxidant capacity of polyphenolics (caffeoylquinic acids and flavonoids) is ascribed to their specific structural features including the number and arrangement of H-donating hydroxyl groups about the nuclear structure (Lattanzio, Cicco, & Linsalata, 2005) .
• 2. Sesquiterpenes: Sesquiterpene lactones consists of three isoprene units and one lactone ring that are mainly found in the leaves and rarely in the head of artichoke (Ramos et al., 2013) .
Cyanoropicrin and grosheimin are main predominant sesquiterpenes in artichoke. It has been revealed that cyanoropicrin could inhibit ROS production in ultraviolet B-irradiated keratinocytes by induction of nuclear translocation of aryl hydrocarbon receptor, as well as by upregulation of transcription of the genes encoding nuclear factor E2-related factor 2 (Nrf2) and NAD(P)H:
quinone oxidoreductase 1 (Nqo1). AhR is an activator of Nrf2/ Nqo1 in a ligand-depend manner and Nrf2 is a transcription factor that upregulates antioxidative enzymes such as Nqo1 (Takei et al., 2015) .
Several potential mechanisms are suggested for antioxidant activity of bioactive compounds of artichoke as follows: lipid peroxidation inhibiting and free radicals scavenging by acting as reducing agents, hydrogen donors, and singlet-oxygen quenchers and metal chelators (Valko et al., 2007) , as well as modulating of ROS-dependent cell functional signaling at several key sites. The modulation effects could be attributed to intercepting free radicals and ROS at the level of critical signaling pathways involving various protein kinases, phosphatases, and transcription factors (Leonarduzzi, Sottero, & Poli, 2010) .
Literature review indicated that artichoke and its extracts could be effective as an antioxidant in prevention and treatment of disease associated with oxidative stress. From a prevention standpoint, artichoke may improve the antioxidative defense system in healthy condition and may protect low-density lipoprotein-cholesterol from oxidation (Brown & Rice-Evans, 1998; Goñi et al., 2005; Jiménez-Escrig et al., 2003; Rezazadeh, Rahmati-Yamchi, et al., 2018; Skarpanska-Stejnborn et al., 2008) . Moreover, in a treatment perspective, artichoke extracts could inhibit oxidative stress when animals are exposed to toxins and when human or animal cells are stimulated by agents that generate reactive oxygen species (AbdelKader et al., 2014; Al-Ahdab, 2014; Brown & Rice-Evans, 1998; Colak et al., 2016; El Morsy & Kamel, 2015; El-Boshy et al., 2017; Gebhardt, 1997; Gebhardt & Fausel, 1997; Heidarian & Rafieian-Kopaei, 2013; Jaleel et al., 2016; Juzyszyn et al., 2008; Kaymaz et al., 2017; Khattab et al., 2016; Löhr et al., 2009; Mehmetcik et al., 2008; Miccadei et al., 2008; Miláčková et al., 2017; Najim et al., 2015; Perez-Garcia et al., 2000; Rahimuddin et al., 2007; Zapolska-Downar et al., 2002) . In addition, artichoke The present study had several limitations. Due to insufficient clinical trials and incomparable in vitro data, we could not perform metaanalysis on human and in vitro studies. In animal studies, there was high heterogeneity between the studies regarding study design, induced disease, type of intervention (artichoke leaf, hydroalcoholic, or aqueous extract of artichoke leaf or head), dosage, duration of study, and oxidative/antioxidative indices measured. Furthermore, in the majority of experimental studies, details on randomization, allocation concealment, and blinding of outcome assessment were not reported, leading to unclear risk of bias in selection bias and detection bias. The risk of performance bias also was high in most of the experimental studies because of lack of blinding participants and researchers. Because the results of animal researches are often translated into clinical practice, the improvement of the methodological quality of animal intervention studies is necessary to lessen the risk of bias.
The strength of the current study was to systematically review all of the relevant human, animal, and in vitro studies. Moreover, metaanalysis of animal studies and subsequent subgroup analysis was conducted to identify the effects of dosage of artichoke extract, study duration, and type of induced disease on the overall effect sizes.
| CONCLUSION
Artichoke is a vegetable that is consumed as a food around the world and indicated health-promoting properties in different disease. The preset meta-analysis provided convincing evidence for antioxidant activity of artichoke in animal models by re-establishment of "redox homeostasis." The antioxidant activity of artichoke extract was not different in low dosage (<1,000 mg/kg) and high dosage (≥1,000 mg/kg). This study suggested the beneficial antioxidant effects of artichoke extract in animals with hepatotoxicity. It should be noted that because of high heterogeneity between animal studies, we could not suggest the best dosage and duration for both animal and human subjects. Therefore, more double-blind placebo-controlled randomized clinical trials are warranted to evaluate antioxidant activity of artichoke and to clarify effective dose, duration, and type (head or leaf) of artichoke and its extract in health or disease.
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